iShares Biotechnology ETF $IBB Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 68.6% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 13,260 shares of the financial services provider’s stock after selling 28,984 shares during the quarter. SG Americas Securities LLC’s holdings in iShares Biotechnology ETF were worth $2,239,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Basepoint Wealth LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter valued at $26,000. Cary Street Partners Financial LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $29,000. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $25,000. Caitlin John LLC purchased a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at about $34,000. Finally, Cornerstone Planning Group LLC acquired a new position in iShares Biotechnology ETF in the 4th quarter worth about $35,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.0%

Shares of IBB stock opened at $190.12 on Thursday. iShares Biotechnology ETF has a 12-month low of $127.11 and a 12-month high of $191.15. The business’s 50 day moving average is $172.32 and its two-hundred day moving average is $171.49.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a $0.0238 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.